The Core will provide necessary support for the creation, selection, characterization, production, and purification of recombinant adenoviruses, as well as the isolation and culture of neonatal rat cardiomyocytes and neonatal and adult mouse cardiomyocytes. The Core is currently used by all of the Projects. The Core facility is and will be directed by Christopher Baines, Ph.D., who was appointed to the faculty in the Department of Pediatrics in 2005, Division of Molecular Cardiovascular Biology. Dr. Baines has extensive experience in cardiomyocyte preparation and in the generation and use of recombinant adenoviral vectors in the study of myocardial cell biology (Baines et al, 2005). He assumed oversight of Core operations in 2005 when Dr. Orlando Bueno left. The necessary personnel are already working in the laboratory and are fully trained. Core C will provide a variety of support services including: a. Production of the shuttle vector plasmid DNA (for distribution to investigators) b. Electroporation of transgene shuttle vector into adenoviral genomic DNA-containing bacteria for recombination c. Identification and purification of positive adenoviral recombinants d. Maintenance of human embryonic kidney (HEK) 293 cells permissive for adenoviral replication e. Amplification of recombinant cultures f. Purification and concentration of recombinant adenoviruses g. Titration of stocks for determination of plaque forming unit (pfu) levels h. Repository service for storage and cataloging of low passage viral stocks to serve as a backup for viral stocks given to investigators i. Weekly preparation of neonatal rat cardiomyocyte cultures j. Preparation of neonatal and adult mouse cardiomyocyte cultures when required

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-PPG-D)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
Travers, Joshua G; Kamal, Fadia A; Robbins, Jeffrey et al. (2016) Cardiac Fibrosis: The Fibroblast Awakens. Circ Res 118:1021-40
Schwanekamp, Jennifer A; Lorts, Angela; Vagnozzi, Ronald J et al. (2016) Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling. Arterioscler Thromb Vasc Biol 36:60-8
Bernardo, Bianca C; Blaxall, Burns C (2016) From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart Failure. Heart Lung Circ 25:425-34
Valiente-Alandi, Iñigo; Schafer, Allison E; Blaxall, Burns C (2016) Extracellular matrix-mediated cellular communication in the heart. J Mol Cell Cardiol 91:228-37
Xiang, Fu-Li; Guo, Minzhe; Yutzey, Katherine E (2016) Overexpression of Tbx20 in Adult Cardiomyocytes Promotes Proliferation and Improves Cardiac Function After Myocardial Infarction. Circulation 133:1081-92
Fang, Ming; Xiang, Fu-Li; Braitsch, Caitlin M et al. (2016) Epicardium-derived fibroblasts in heart development and disease. J Mol Cell Cardiol 91:23-7
James, Jeanne; Robbins, Jeffrey (2016) Healing a Heart Through Genetic Intervention. Circ Res 118:920-2
Travers, Joshua G; Schafer, Allison E; Blaxall, Burns C (2016) GRK2 in Lymphocytes: Expanding the Arsenal of Heart Failure Prognostics. Circ Res 118:1049-51
Previs, Michael J; Mun, Ji Young; Michalek, Arthur J et al. (2016) Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function. Proc Natl Acad Sci U S A 113:3239-44
Gupta, Manish K; McLendon, Patrick M; Gulick, James et al. (2016) UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts. Circ Res 118:1894-905

Showing the most recent 10 out of 108 publications